Press release
Oct 25, 2023

Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-stage Development Progress

Tokyo, Japan and Cambridge, UK, 25 October 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) will hold an R&D Day on Friday, 10 November 2023, at 4 pm JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event.


Date: Friday, 10 November 2023 

Time: 4 pm – 5 pm JST (7 am – 8 am GMT) 


  1. Chris Cargill, President and CEO  - Corporate presentation, vision, strategy and progress  
  2. Dr. Matt Barnes, Executive Officer, Head of UK R&D - Progress in UK R&D
  3. Dr. Satoshi Tanaka, Executive Officer, President of Idorsia Pharmaceuticals Japan, a Sosei Group company - Development and Sales in Japan and APAC 
  4. Hironoshin Nomura, Executive Officer, CFO - Supplementary Explanation for Q3FY2023 Results
  5. Q&A


The R&D Day will be conducted in Japanese and English with simultaneous translation.

Archive streaming will be available on the company’s website shortly after the event. 


– ENDS –